Residents across the Wolverine State have been hit with a health alert that sounds like it's straight out of a bad trip. Michigan's health authorities and the FDA have dropped the hammer on a trendy snack, warning everyone to toss out any Diamond Shruumz-brand concocted treats that boast a "proprietary blend" of mushrooms, such as reishi and lion’s mane. These 'healthy' edibles – found masquerading as microdosing chocolate bars, infused cones, or gummies – are now at the center of a multi-state sickness saga.
"People in multiple states have become ill after eating these products, reporting a variety of severe symptoms," quotes Dr. Natasha Bagdasarian, the chief medical executive, in a warning issued by the Michigan Department of Health and Human Services. With the FDA and CDC diving into an intensive investigation since June 7, it’s clear that the concern is no minor hiccup. While no cases have popped up in Michigan itself yet, the spate of illnesses spanning across 16 states signals an unnerving trend tied to these deceptively dessert-like products.
Retail locations nationwide, including smoke and vape shops and outlets selling hemp-derived or CBD offerings, have been told to put a freeze on selling any Diamond Shruumz items. According to a report by ClickOnDetroit, alarmed officials noted that 25 of the ill consumers sought medical care, with 16 cases serious enough to require hospitalization. Symptoms range from seizures and confusion to abnormal heartbeats and nausea, framing a concerning picture for consumers and health experts alike.
For those who may have dabbled in these shroom-stuffed snacks and are now feeling the repercussions, medical attention should be sought immediately. A Poison Help Line has been set up at 800-222-1222 for reporting symptoms and getting critical information. Health care providers haven't been excluded from the loop; they're being prompted to report these adverse events to their local health department or poison control.
The investigation is ongoing, and Michigan's MDHHS, in tune with the FDA, pledges to keep the public posted.
